title: Muscle contusion injuries: current treatment options.
abstract: Muscle contusion is second only to strain as the leading cause of morbidity from sports-related injuries. Severity depends on the site of impact, the activation status of the muscles involved, the age of the patient, and the presence of fatigue. The diagnosis has traditionally been one of clinical judgment; however, newer modalities, including ultrasonography, magnetic resonance imaging, and spectroscopy, are becoming increasingly important in both identifying and delineating the extent of injury. Although controlled clinical studies are scarce, animal research into muscle contusions has allowed the description of the natural healing process, which involves a complex balance between muscle repair, regeneration, and scar-tissue formation. Studies are being performed to evaluate the effects of anti-inflammatory medications, corticosteroids, operative repair, and exercise protocols. Prevention and treatment of complications such as myositis ossificans have also been stressed, but recognition may improve the outcome of these ubiquitous injuries.
authors.affiliation: Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT 06511, USA.
authors.forename: J M
authors.initials: JM
authors.lastname: Beiner
authors.forename: P
authors.initials: P
authors.lastname: Jokl
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001265:Athletic Injuries / Q000145:classification / Q000209:etiology / Q000628:therapy*; D003288:Contusions / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D017679:Cryotherapy; D006801:Humans; D007103:Immobilization; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000293:injuries* / Q000503:physiopathology / Q000648:ultrastructure; D009221:Myositis Ossificans / Q000209:etiology; D051381:Rats; D014945:Wound Healing
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal